|
Variable
|
GIRK1
|
p value
|
|---|
| |
Low expression (n = 22) (31%)
|
High expression (n = 50) (69%)
| |
|---|
|
Age at surgery (yrs)
| | | |
|
≤60
|
8 (11 %)
|
19 (26 %)
| |
|
>60
|
14 (20 %)
|
31 (43 %)
|
0.90
|
|
Sex
| | | |
|
Male
|
17 (24 %)
|
35 (48 %)
| |
|
Female
|
5 (7 %)
|
15 (21 %)
|
0.53
|
|
Tumor status
| | | |
|
T1
|
10 (14 %)
|
11 (15 %)
| |
|
T2
|
10 (14 %)
|
25 (35 %)
|
0.07
|
|
T3
|
2 (3 %)
|
14 (19 %)
| |
|
Nodal status
| | | |
|
N0
|
17 (24 %)
|
26 (36 %)
| |
|
N1
|
3 (4 %)
|
3 (4 %)
|
0.02
|
|
N2
|
2 (3 %)
|
21 (29 %)
| |
|
Stage
| | | |
|
IA/IB
|
16 (22 %)
|
19 (26 %)
| |
|
IIA/IIB
|
4 (6 %)
|
10 (14 %)
|
0.02
|
|
III A
|
2 (3 %)
|
21 (29 %)
| |
|
Histology
| | | |
|
Adenocarcinoma
|
15 (21 %)
|
26 (36 %)
| |
|
Squamous cell carcinoma
|
6 (8 %)
|
22 (30 %)
|
0.40
|
|
Large cell carcinoma
|
1 (2 %)
|
2 (3 %)
| |
